CoChat

AACR Project GENIE: 100,000 Cases and Beyond

Open access
Pugh, Trevor J., Bell, Jonathan L., Bruce, Jeff P., Doherty, Gary J., Galvin, Matthew, Green, Michelle F., Hunter-Zinck, Haley, Kumari, Priti, Lenoue-Newton, Michele L., Li, Marilyn M., Lindsay, James, Mazor, Tali, Ovalle, Andrea, Sammut, Stephen-John, Schultz, Nikolaus, Yu, Thomas V., Sweeney, Shawn M., Bernard, Brady, for the AACR Project GENIE Consortium, Genomics and Analysis Working Group · 2022 · Cancer Discovery
Cited by 106

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international pan-cancer registry with the goal to inform cancer research and clinical care worldwide. Founded in late 2015, the milestone GENIE 9.1-public release contains data from >110,000 tumors from >100,000 people treated at 19 cancer centers from the United States, Canada, the United Kingdom, France, the Netherlands, and Spain. Here, we demonstrate the use of these real-world data, harmonized through a centralized data resource, to accurately predict enrollment on genome-guided trials, discover driver alterations in rare tumors, and identify cancer types without actionable mutations that could benefit from comprehensive genomic analysis. The extensible data infrastructure and governance framework support additional deep patient phenotyping through biopharmaceutical collaborations and expansion to include new data types such as cell-free DNA sequencing. AACR Project GENIE continues to serve a global precision medicine knowledge base of increasing impact to inform clinical decision-making and bring together cancer researchers internationally. Significance: AACR Project GENIE has now accrued data from >110,000 tumors, placing it among the largest repository of publicly available, clinically annotated genomic data in the world. GENIE has emerged as a powerful resource to evaluate genome-guided clinical trial design, uncover drivers of cancer subtypes, and inform real-world use of genomic data. This article is highlighted in the In This Issue feature, p. 2007

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-1547

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 106

Metadata

Authors
Pugh, T. J., Bell, J. L., Bruce, J. P., Doherty, G. J., Galvin, M., Green, M. F., Hunter-Zinck, H., Kumari, P., Lenoue-Newton, M. L., Li, M. M., Lindsay, J., Mazor, T., Ovalle, A., Sammut, S.-J., Schultz, N., Yu, T. V., Sweeney, S. M., Bernard, B., & for the AACR Project GENIE Consortium, G. A. A. W. G.
Venue
Cancer Discovery
Published
2022-07-12
Volume
12
Issue
9
Pages
2044-2057
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W4285077014
Cited by
106
References
15
FWCI
7.03
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AACR Project GENIE: 100,000 Cases and Beyond. https://app.cochat.ai/papers/10.1158/2159-8290.cd-21-1547
The paper
Pugh, T. J., Bell, J. L., Bruce, J. P., Doherty, G. J., Galvin, M., Green, M. F., Hunter-Zinck, H., Kumari, P., Lenoue-Newton, M. L., Li, M. M., Lindsay, J., Mazor, T., Ovalle, A., Sammut, S.-J., Schultz, N., Yu, T. V., Sweeney, S. M., Bernard, B., & for the AACR Project GENIE Consortium, G. A. A. W. G. (2022). AACR Project GENIE: 100,000 Cases and Beyond. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-21-1547

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.